FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
FundaMental Pharma has raised $2.9M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
FundaMental Pharma's investors include HTGF (High-Tech Gruenderfonds), BioGeneration Ventures, Novartis Venture Fund, Thuja Capital, coparion.
FundaMental Pharma is headquartered in Heidelberg, Germany.
FundaMental Pharma is a neuroscience company with a portfolio at the preclinical stage.
FundaMental Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"FundaMental Pharma — Funding & Investors." VCBacked, April 11, 2024, https://www.vcbacked.co/company/fundamental-pharma. Accessed September 30, 2026.
VCBacked. (2024). FundaMental Pharma — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/fundamental-pharma
{{cite web |title=FundaMental Pharma — Funding & Investors |url=https://www.vcbacked.co/company/fundamental-pharma |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated